JoseGCastroMDFIDSA (He/Him)

Professor of Clinical Medicine, Division of Infectious diseases, University of Miami School of Medicine. Clinical Chief; Division of Infectious Diseases

Join to view full profile

Dr. Castro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Castro's full profile

Already have an account?

Office
1120 NW 14 st
Suite 857
Miami, FL 33136
Phone+1 305-243-3838

Fax+1 305-243-5765

Summary

Dr. Jose Castro is an infectious disease specialist in Miami, FL and is affiliated with multiple hospitals in the area, including University of Miami Hospital, Jackson Health System, and University of Miami Hospital and Clinics. He received his medical degree from Cayetano Heredia University and has been in practice 29 years. He also speaks multiple languages, including Spanish. He is experienced in mandibular space infection, ventriculoperitoneal shunt infection, immunodermatology, and emerging infectious diseases. He has more than 40 publications and over 500 citings.

Education & Training

University of Miami/Jackson Health SystemFellowship, Infectious Disease, 1997 - 1999
University of Miami MD, Comprehensive HIV Program, 1996 - 1997
MedStar Health (Baltimore)Residency, Internal Medicine, 1993 - 1996
Cayetano Heredia UniversityClass of 1988

Certifications & Licensure

FL State Medical License 1996 - 2026
American Board of Internal Medicine Infectious Disease

Clinical Trials

Patch Study - Intervention for HIV Positive Smokers Start of enrollment: 2016 May 01
Completed
Not Applicable
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults Start of enrollment: 2015 Mar 26
Completed
Phase 3

Publications & Presentations

PubMed

61 citations
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.
Cameron R Wolfe, Kay M Tomashek, Thomas F Patterson, Carlos A Gomez, Vincent C Marconi
The Lancet. Respiratory Medicine. 2022-09-01
99 citations
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-in...

The Lancet. HIV. 2018-05-01
50 citations
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority...
Jean-Michel Molina, Kathleen Squires, Paul E. Sax, Pedro Cahn, Johan Lombaard
The Lancet. HIV. 2020-01-01

Press Mentions

Hospital Admissions Among People Who Inject Opioids Following Syringe Services Program ImplementationMay 12th, 2020
Coronavirus Update: Remdesivir Credited with Saving Patient at Hollywood Regional Memorial HospitalMay 3rd, 2020